Deregulation and Targeting of TP53 Pathway in Multiple MyelomaKatarina Jovanović, Salomon Manier, Guillaume Escure et al.|Frontiers in Oncology|2019Cited by 80
Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypothesesFrançois Lersy, Stéphane Kremer, Thibault Willaume et al.|Journal of Neurology|2020Cited by 55
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA studyVincent Camus, Hervé Tilly, Cédric Rossi et al.|Blood Advances|2021Cited by 51
A new role of glutathione peroxidase 4 during human erythroblast enucleationHakim Ouled‐Haddou, Loïc Garçon, Kahia Messaoudi et al.|Blood Advances|2020Cited by 34
Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life populationZoé Van de Wyngaert, Eileen M. Boyle, Benjamin Carpentier et al.|British Journal of Haematology|2019Cited by 29